2型糖尿病的代谢组学特征:系统综述与整合分析
前瞻性研究的Meta分析显示,异亮氨酸、亮氨酸、缬氨酸、酪氨酸、苯丙氨酸、谷氨酸、丙氨酸、戊酰肉碱(C5)、棕榈酰肉碱(C16)、棕榈酸和亚油酸与T2D风险升高相关,而丝氨酸、谷氨酰胺和溶血磷脂酰胆碱C18:2降低风险;在传统风险因素基础上加入这些代谢物对T2D预测有轻微改善。通路分析识别出17条可能在T2D过程中改变的代谢通路。
要点
- 支链氨基酸(异亮氨酸、亮氨酸、缬氨酸)及芳香族氨基酸与T2D风险升高相关。
- 丝氨酸、谷氨酰胺和溶血磷脂酰胆碱C18:2与T2D风险降低相关。
- 加入代谢物对T2D预测的改善仅轻微超越传统风险因素。
核心结论
- 识别出多种与T2D相关的代谢物和代谢通路,为预防和药物治疗提供潜在生物标志物和新靶点。
研究设计与样本
- Meta分析使用STATA 14.0在随机效应模型下进行,并采用MetaboAnalyst和R 3.5.2进行生物信息学分析。
主要发现
- 前瞻性研究的Meta分析表明,异亮氨酸、亮氨酸、缬氨酸、酪氨酸、苯丙氨酸、谷氨酸、丙氨酸、戊酰肉碱(C5)、棕榈酰肉碱(C16)、棕榈酸和亚油酸与T2D风险升高相关。
- 丝氨酸、谷氨酰胺和溶血磷脂酰胆碱C18:2与T2D风险降低相关。
- 在西方国家亚组中,精氨酸和甘氨酸与T2D风险升高相关;在巢式病例对照亚组中,甜菜碱与T2D负相关。
- 在预测分析中加入这些代谢物后,对T2D的预测较传统风险因素有轻微改善。
- 通路分析识别出17条可能在T2D过程中改变的代谢通路,且代谢物相关基因富集于与T2D相关的功能和通路。
临床怎么用
- 这些代谢物可作为T2D风险分层和早期预警的潜在生物标志物,但预测增益有限,尚不能替代传统风险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Metabolic signatures have emerged as valuable signaling molecules in the biochemical process of type 2 diabetes (T2D). To summarize and identify metabolic biomarkers in T2D, we performed a systematic review and meta-analysis of the associations between metabolites and T2D using high-throughput metabolomics techniques. METHODS: We searched relevant studies from MEDLINE (PubMed), Embase, Web of Science, and Cochrane Library as well as Chinese databases (Wanfang, Vip, and CNKI) inception through 31 December 2018. Meta-analysis was conducted using STATA 14.0 under random effect. Besides, bioinformatic analysis was performed to explore molecule mechanism by MetaboAnalyst and R 3.5.2. RESULTS: Finally, 46 articles were included in this review on metabolites involved amino acids, acylcarnitines, lipids, carbohydrates, organic acids, and others. Results of meta-analysis in prospective studies indicated that isoleucine, leucine, valine, tyrosine, phenylalanine, glutamate, alanine, valerylcarnitine (C5), palmitoylcarnitine (C16), palmitic acid, and linoleic acid were associated with higher T2D risk. Conversely, serine, glutamine, and lysophosphatidylcholine C18:2 decreased risk of T2D. Arginine and glycine increased risk of T2D in the Western countries subgroup, and betaine was negatively correlated with T2D in nested case-control subgroup. In addition, slight improvements in T2D prediction beyond traditional risk factors were observed when adding these metabolites in predictive analysis. Pathway analysis identified 17 metabolic pathways may alter in the process of T2D and metabolite-related genes were also enriched in functions and pathways associated with T2D. CONCLUSIONS: Several metabolites and metabolic pathways associated with T2D have been identified, which provide valuable biomarkers and novel targets for prevention and drug therapy.
引用
- Sun Y, Gao HY, Fan ZY, et al. Metabolomics Signatures in Type 2 Diabetes: A Systematic Review and Integrative Analysis. J Clin Endocrinol Metab. 2020. PMID: 31782507. doi:10.1210/clinem/dgz240
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。